Wyeth Articles
FDA pre-emption case taken up by SCOTUS
28 January 2008
Pharma majors enter CSN experimental medicines consortium
28 January 2008
Wyeth/Teva extend Protonix standstill
28 January 2008
57% of teen patients on Enbrel see PASI 75
21 January 2008
Wyeth licenses Mochida's portfolio of TRPV1 antagonists
21 January 2008
Akrimax buys Wyeth's Rouses Point plant
21 January 2008
Japan stock market week toJan 14, 2008
21 January 2008
Methylnaltrexone NDA sees 3-month extension
21 January 2008
French drug sales rose 4%-4.5% in 2007
21 January 2008
Encouraging early AD data with anti-TNF drug
21 January 2008
Patent expiry for 2008 provides generic opportunity
14 January 2008
Wyeth extends TNF accord with Ablynx for one more year
7 January 2008
UK govt claims 300 children saved by vacc
7 January 2008
Wyeth files additional Viviant data with FDA
24 December 2007
China's largest pharmacy chain signs 16 drug firms
24 December 2007
FDA pre-emption case at the US Supreme Court
17 December 2007
PhRMA details Mexico flood relief by members
17 December 2007
Wyeth makes senior executive changes
10 December 2007
Raven Bio and Wyeth extend MAb evaluation period
10 December 2007
Stock Commentary - New York week to Nov 26, 2007
3 December 2007
Headlines 25 years ago this week....
3 December 2007
EC approves Wyeth's Torisel in advanced RCC
3 December 2007
EAEPC attacks EAASM as "sheer propaganda tool"
3 December 2007
Andrew Davidson becomes Wyeth's principal corporate officer
26 November 2007
Call for EU review of parallel trade by EAASM
26 November 2007
Wyeth's DR Protonix gets FDA thumbs up
26 November 2007
Drug sales up 5% in year to September 2007
26 November 2007
Japanese generic drug listings for November
21 November 2007
US Rx drug market in relative decline
12 November 2007
Wyeth Minnesota hormone law suit dismissed
5 November 2007
Meda to acquire Recip for $407M+
5 November 2007
Wyeth submits Tygacil sNDA for CAP
29 October 2007
New head of Wyeth France to manage future growth
29 October 2007
Ligand earns Wyeth milestone
22 October 2007
Drug sales up 5% in year to August 2007
22 October 2007
Drugmakers withdraw child cold remedies
22 October 2007
Wyeth to pay $134.5 M in HR law suit
22 October 2007
Ablynx to float on Euronext Brussels
15 October 2007
Wyeth sets sights on Japanese market
15 October 2007
Wyeth to buy Scot spin-out Haptogen
15 October 2007
Bernard Poussot elected president and CEO of Wyeth
8 October 2007
Wyeth to repurchase $5B of shares
8 October 2007
Solvay reduces 2010 pharma sales forecast
8 October 2007
Patent expiries will reduce bipolar drug market $400M
1 October 2007
Headlines 25 years ago this week....
1 October 2007
Toricel gets CHMP nod as first-line RCC drug
1 October 2007
Drug sales up 5% in year to July 2007
24 September 2007
Wyeth licenses Flamel's delivery technology
24 September 2007
Boeh Ing and Ablynx sign development deal
17 September 2007
Biovitrum's 2nd-qtr 2007 income soars 33%
10 September 2007
Wyeth and Progenics file methylnaltrexone with TGA
3 September 2007
Barr's Portia approved and launched in Canada
3 September 2007
Pfizer-Wyeth merger speculation fuels debate
3 September 2007
EMEA OKs BeneFix modifications
3 September 2007
Wyeth/ViroPharma discontinue Ph II study of HCV-796
20 August 2007
Stock Commentary - New York week to Aug 13, 2007
20 August 2007
Actavis' generic Inderal LA gets US approval
20 August 2007
Wyeth rated best in WSJ patent scorecard
20 August 2007
US unapproved drug access "flawed"
20 August 2007
US FDA asks for 2nd trial of bifeprunox
20 August 2007
Neuromed hires Mario Orland as VP, marketing
13 August 2007
Biovitrum enters Nordic BeneFIX co-promo deal
13 August 2007
FDA clears Teva's generic Protonix
13 August 2007
Stock Commentary - New York week to July 30, 2007
6 August 2007
Wyeth's Lybrel now on sale in USA
6 August 2007
Wyeth's 2nd-qtr net income climbs 12.5%
30 July 2007
Tentative FDA OK for second Pristiq indication
30 July 2007
Novartis
30 July 2007
UK Cabinet minister to avoid COI
26 July 2007
Novavax licenses VLP from Wyeth
26 July 2007
Wyeth to submit Tygacil sNDA for CAP
23 July 2007
Karo Bio and Wyeth extend LXR drug deal
16 July 2007
Wyeth invests L3.25M in UK site
9 July 2007
New appointments at Wyeth
9 July 2007
Progenics/Wyeth: positive data from OIC trial
9 July 2007
Wyeth seeks US block on generic Protonix
2 July 2007
Galapagos gets $1.4M milestone from Wyeth
2 July 2007
Alzheimer's population to hit 63M in Asia
18 June 2007
US FDA accepts NDA for Wyeth/Progenics' OIC drug
18 June 2007
Isogenica signs peptide deal with Wyeth
11 June 2007
Poland
11 June 2007
Bifeprunox prolongs time to deterioration
4 June 2007
Wyeth's Pristiq extends relapse time in MDD
4 June 2007
Stock Commentary - Europe - week to May 21, 2007
28 May 2007
- Is failure to adopt business process management putting the pharma industry at risk?
- New Zealand declines Alexion's funding application for Solaris
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
- Elan makes "transformational" acquisitions and a divestment
